Invasive pulmonary aspergillosis associated with marijuana use in a man with colorectal cancer.
Cescon
David W
DW
Department of Medicine, University of Toronto, Toronto, Canada.
Page
Andrea V
AV
Richardson
Susan
S
Moore
Malcolm J
MJ
Boerner
Scott
S
Gold
Wayne L
WL
D000368:Aged; D000932:Antiemetics / Q000009:adverse effects*; D000935:Antifungal Agents / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects; D001228:Aspergillosis / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology; D001232:Aspergillus fumigatus / Q000302:isolation & purification; D002188:Cannabis / Q000382:microbiology*; D017024:Chemotherapy, Adjuvant / Q000009:adverse effects; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D004340:Drug Contamination; D006801:Humans; D008172:Lung Diseases, Fungal / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000556:secondary; D008297:Male; D008385:Marijuana Smoking / Q000009:adverse effects*; D009325:Nausea / Q000139:chemically induced / Q000517:prevention & control*; D010936:Plant Extracts / Q000009:adverse effects; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
D000932:Antiemetics; D000935:Antifungal Agents; D010936:Plant Extracts